HVEM (14-39)

HVEM (14-39) is a BTLA-binding peptide (K_D = 0.102 μM) that enhances T cell activation, proliferation, and effector memory differentiation. It exhibits immunomodulatory and anti-tumor properties by inhibiting tumor cell proliferation and inducing apoptosis, making it a valuable tool for cancer immunology research in both in vitro and in vivo settings.